PST-611, a first in class non-viral vectorized therapy expressing human transferrin, a highly potent iron regulator.

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

The EXODUS system is an advanced exosome isolation technology, offering significant improvements in yield, purity, and ...

Canola and a team of researchers analyzed ferritin, which stores iron and increases during acute inflammation, and ...